Abstract:BACKGROUND CONTEXT While Teriparatide use for osteoporotic patients has been well established, it has not been thoroughly examined among osteopenic patients and those with unremarkable bone health. Patients have shown improved functional outcomes and lower failure rates for lumbar fusion when placed on Teriparatide, but most studies place a generalization on patients with poor bone health. As a result, there is no consensus whether Teriparatide use can specifically improve lumbar fusion success rates in osteopenic patients. PURPOSE The purpose of this study is to compare readmissions, revisions, and complication rates across osteoporotic, osteopenic, and normal bone health patients undergoing primary lumbar fusion with and without Teriparatide. STUDY DESIGN/SETTING N/A PATIENT SAMPLE N/A OUTCOME MEASURES N/A METHODS A PearlDiver Database search query was conducted using International Classifcation of Diseases (ICD) and Current Procedural Terminology (CPT) codes to find patients undergoing primary lumbar fusion with and without Teriparatide, and subclassifying these groups by bone health. This resulted in 4,931 patients who underwent lumbar fusion while previously being on Teriparatide, of which 4,136 were osteoporotic, 239 were osteopenic, and 556 had appropriate bone health. These patients were matched by age, gender, Elixhauser comorbidity index (ECI), obesity, and bisphosphonate use in a 1:5 ratio to lumbar fusion patients who were not using Teriparatide. This resulted in 1,195 osteopenics, 20,680 osteoporotics, and 2,780 appropriate bone health patients in the non-Teriparatide groups. Chi-square analysis was used to compare baseline demographics between operative groups, as well as medical complication, 90-day postoperative readmission, and 2-year revision rates. Logarithmic regression analysis was used to analyze associations between Teriparatide use and associated outcomes. RESULTS Within the teriparatide group, both osteopenic and normal bone health patients had significantly lower rates of 90-day medical complications than the osteoporotic patients (p<0.001). Osteopenic and osteoporotic patients on Teriparatide had similar 90-day readmission rates (23.1% vs 25.1%, respectively, p=0.6239) and 2-year revision rates (35.6% vs 36.8%, p=0.7991). When comparing osteopenic patients using and not using Teriparatide, both groups demonstrated similar medical complication rates, but the Teriparatide group demonstrated lower 90-day readmission rates compared to their non-Teriparatide counterparts (23.1% vs 31.4%, p=0.0099). Logistic regression analysis revealed a lower risk of revisions when osteopenic patients use Teriparatide as opposed to without (OR: 1.54; 99% CI:1.29-1.84; P<0.001). CONCLUSIONS Osteopenic patients using Teriparatide displayed lower medical complication rates compared to osteoporotic patients using Teriparatide, while displaying similar 90-day readmission and 2-year revision rates. Osteopenic patients displayed lower readmission rates and were associated with smaller revision rates following lumbar fusion when on Teriparatide compared to those not using Teriparatide. Surgeons should consider early supplementation of Teriparatide for potential osteopenic lumbar fusion candidates prior to patients reaching osteoporotic status. FDA Device/Drug Status This abstract does not discuss or include any applicable devices or drugs.

Effect of Teriparatide Versus Zoledronate on Posterior Lumbar Interbody Fusion in Postmenopausal Women with Osteoporosis

The Effect of Daily Teriparatide versus One-Time Annually Zoledronic Acid Administration After Transforaminal Lumbar Interbody Fusion in Osteoporotic Patients

Effect of Teriparatide on Bone Mineral Density and Fracture in Postmenopausal Osteoporosis: Meta-Analysis of Randomised Controlled Trials

Effects of combined teriparatide and zoledronic acid on posterior lumbar vertebral fusion in an aged ovariectomized rat model of osteopenia.

Effectiveness of Teriparatide for Spine Fusion in Osteoporotic Patient: A Systematic Review and Meta-Analysis of Comparative Studies

Is Teriparatide Superior in Treating Osteoporotic Vertebral Compression Fractures in Comparison to Bisphosphonates Treatment Alone: A 2-Year Retrospective Analysis

The Relation Between Zoledronic Acid Infusion and Interbody Fusion in Patients Undergoing Transforaminal Lumbar Interbody Fusion Surgery

Meta-analysis of Instrumented Posterior Interbody Fusion Versus Instrumented Posterolateral Fusion in the Lumbar Spine.

P295. Teriparatide use in osteopenic patients undergoing lumbar fusion

Efficacy of the Combination of Teriparatide and Denosumab in the Treatment of Postmenopausal Osteoporosis: A Meta-Analysis

The Effect of Oblique Lumbar Interbody Fusion Compared with Transforaminal Lumbar Interbody Fusion Combined with Enhanced Recovery after Surgery Program on Patients with Lumbar Degenerative Disease at Short-Term Follow-Up.

Effect of bisphosphonates or teriparatide on mechanical complications after posterior instrumented fusion for osteoporotic vertebral fracture: a multi-center retrospective study

Impact of Teriparatide and Denosumab on Clinical and Radiographic Outcomes in Osteoporotic Vertebral Compression Fractures

Biotransformation of the methylenedioxy moeity of oxolinic acid in man.

Teriparatide in postmenopausal osteoporosis: uncovering novel insights into efficacy and safety compared to other treatments - a systematic review and meta-analysis

Effect of Zoledronic Acid on Spinal Fusion Outcomes in an Ovariectomized Rat Model of Osteoporosis

Effectiveness of teriparatide in in improving healing rates and bone-turnover markers of osteoporotic hip fracture: a meta-analysis

Comparison of Bisphosphonates Versus Teriparatide in Therapy of the Glucocorticoid-Induced Osteoporosis (GIOP): A Meta-Analysis of Randomized Controlled Trials

Highly fluorescent carbon quantum dots as nanoprobes for sensitive and selective determination of mercury (II) in surface waters.

Aspects of parasexual analysis in Aspergillus parasiticus.

Teriparatide alone versus vertebroplasty on pain control and radiographic outcomes after osteoporotic vertebral compression fracture